New opinion on the issue of proton pump inhibitor-refractory gastroesophageal reflux disease
The aim of review. To present up-to-date data on the causes of proton pump inhibitor-refractory gastroesophageal reflux disease (GERD) development.Summary. The prevalence of GERD reaches 20–30% of population, and approximately 40–50% of patients do not respond to standard treatment by proton pump in...
Saved in:
Main Authors: | Yu. V. Yevsyutina, A. S. Trukhmanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2014-11-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1133 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastroesophageal reflux disease, resistant to proton pump inhibitors
by: V. O. Kaybysheva, et al.
Published: (2011-06-01) -
Comparison of clinical and pharmacodynamic features of proton pump inhibitors efficacy in gastroesophageal reflux disease
by: O. A. Storonova, et al.
Published: (2015-12-01) -
How to Make the Right Choice of Proton Pump Inhibitor for Patients with Gastroesophageal Reflux Disease?
by: Yu. V. Evsyutina
Published: (2023-06-01) -
Increase in treatment compliance reveals new options of treatment of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-05-01) -
Contemporary Approaches to the Treatment of Gastroesophageal Reflux Disease
by: Boris D. Starostin
Published: (2019-03-01)